ATE256746T1 - Subeinheits-impfstoff gegen hundecoronavirus - Google Patents

Subeinheits-impfstoff gegen hundecoronavirus

Info

Publication number
ATE256746T1
ATE256746T1 AT92201136T AT92201136T ATE256746T1 AT E256746 T1 ATE256746 T1 AT E256746T1 AT 92201136 T AT92201136 T AT 92201136T AT 92201136 T AT92201136 T AT 92201136T AT E256746 T1 ATE256746 T1 AT E256746T1
Authority
AT
Austria
Prior art keywords
ecoronavirus
subunity
vaccine against
ccv
against dog
Prior art date
Application number
AT92201136T
Other languages
English (en)
Inventor
Thomas David Kay Brown
Brian Colin Horsburgh
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE256746T1 publication Critical patent/ATE256746T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92201136T 1991-04-25 1992-04-22 Subeinheits-impfstoff gegen hundecoronavirus ATE256746T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91303737 1991-04-25

Publications (1)

Publication Number Publication Date
ATE256746T1 true ATE256746T1 (de) 2004-01-15

Family

ID=8208264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92201136T ATE256746T1 (de) 1991-04-25 1992-04-22 Subeinheits-impfstoff gegen hundecoronavirus

Country Status (11)

Country Link
US (1) US5661006A (de)
EP (1) EP0510773B1 (de)
JP (1) JP3420258B2 (de)
AT (1) ATE256746T1 (de)
AU (1) AU645417B2 (de)
CA (1) CA2066940C (de)
DE (1) DE69233270T2 (de)
DK (1) DK0510773T3 (de)
ES (1) ES2213743T3 (de)
NZ (1) NZ242471A (de)
PT (1) PT510773E (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
DE69332375T2 (de) * 1992-05-08 2003-02-13 Pfizer Hundecoronavirus s gen und verwendung davon
US20020195417A1 (en) * 2001-04-20 2002-12-26 Steinberg Dan A. Wet and dry etching process on <110> silicon and resulting structures
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US6772918B2 (en) * 2002-10-07 2004-08-10 Justrite Manufacturing Company Safety can
US8080642B2 (en) 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) * 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
ES2355702T3 (es) * 2005-10-26 2011-03-30 Canio Buonavoglia Coronavirus canino pantrópico.
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CN112301153B (zh) * 2020-02-06 2023-09-08 广州普世君安生物科技有限公司 一种快速检测犬冠状病毒（ccv）的rda方法及试剂盒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4722848A (en) * 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4470967A (en) * 1982-10-05 1984-09-11 Iowa State University Research Foundation Lectin-containing anti-viral vaccines for domestic animals and method of preparation
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
EP0138242A1 (de) * 1983-09-07 1985-04-24 Duphar International Research B.V Verfahren zur Herstellung von DNS,die Komplementär zum Genom von Coronaviren ist
HUT45559A (en) * 1987-01-16 1988-07-28 Duphar Int Res Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
US5202430A (en) * 1990-01-16 1993-04-13 University Of Tennessee Transmissible gastroenteritis virus genes
GB9001766D0 (en) * 1990-01-25 1990-03-28 Univ Court Of The University O Vaccines
EP0524672A1 (de) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV-Impfstoff
GB9203509D0 (en) * 1992-02-19 1992-04-08 British Tech Group Ibv spike protein(2)

Also Published As

Publication number Publication date
CA2066940A1 (en) 1992-10-26
US5661006A (en) 1997-08-26
ES2213743T3 (es) 2004-09-01
AU645417B2 (en) 1994-01-13
JPH05260976A (ja) 1993-10-12
DE69233270T2 (de) 2004-09-30
DK0510773T3 (da) 2004-04-19
AU1513192A (en) 1992-10-29
DE69233270D1 (de) 2004-01-29
NZ242471A (en) 1993-05-26
EP0510773A1 (de) 1992-10-28
CA2066940C (en) 2003-10-21
PT510773E (pt) 2004-04-30
EP0510773B1 (de) 2003-12-17
JP3420258B2 (ja) 2003-06-23

Similar Documents

Publication Publication Date Title
ATE256746T1 (de) Subeinheits-impfstoff gegen hundecoronavirus
BR0113109A (pt) Anticorpos antil-il-12, composições, métodos e usos
DK157087D0 (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
HK1130069A1 (en) Tumor antigen based on products of the tumor suppressor gene wt1 wt1
GR3017770T3 (en) Feline infectious peritonitis virus diagnostic tools.
DE3882599D1 (de) Hundecoronavirus-impfstoff.
DK0652287T3 (da) Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom
DK0653489T3 (da) Coccidiosisvaccine til fjerkræ
ATE126274T1 (de) Rekombinanter impfstoff gegen marek&#39;s krankheit.
DK0709460T3 (da) Fjerkrævaccine imod coccidiosis
DE68909041D1 (de) Eimeria tenella-Vakzin.
DE69023140D1 (de) Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.
DK165359C (da) Vaccine mod smitsom bronkitis hos daggamle kyllinger, samt virusstamme indeholdt i vaccinen
Morgan et al. Recombinant vaccine against Marek's disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0510773

Country of ref document: EP

REN Ceased due to non-payment of the annual fee